Agilent Technologies, Inc. (A) News
Filter A News Items
A News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
A News Highlights
- For A, its 30 day story count is now at 38.
- Over the past 26 days, the trend for A's stories per day has been choppy and unclear. It has oscillated between 1 and 8.
- The most mentioned tickers in articles about A are ENTA, JD and NIO.
Latest A News From Around the Web
Below are the latest news stories about Agilent Technologies Inc that investors may wish to consider to help them evaluate A as an investment opportunity.
10 Best Stocks Under $200 According to Edgar Wachenheim’s Greenhaven AssociatesIn this article, we will take a look at the 10 best stocks under $200 according to Edgar Wachenheim’s Greenhaven Associates. You can skip our detailed analysis of Edgar Wachenheim’s history, investment philosophy, and hedge fund performance, and go directly to the 5 Best Stocks Under $200 According to Edgar Wachenheim’s Greenhaven Associates. Greenhaven Associates […] |
7 Hot Penny Stocks to Buy for December That Are Positioned to PopThese penny stocks remain positioned to run upwards in the near term. |
Agilent Technologies, Inc. 2021 Q4 - Results - Earnings Call PresentationThe following slide deck was published by Agilent Technologies, Inc. in conjunction with their 2021 Q4 earnings call.... |
Agilent Technologies, Inc. (A) CEO Mike McMullen on Q4 2021 Results - Earnings Call TranscriptAgilent Technologies, Inc. (A) Q4 2021 Earnings Conference Call November 22, 2021 4:30 PM ET Company Participants Parmeet Ahuja - Vice President of Investor Relations Mike McMullen - President and Chief Executive Officer Bob McMahon - Senior Vice President and Chief Financial Officer Jacob Thaysen - President, Life Sciences and... |
Analysts Offer Insights on Healthcare Companies: Agilent (A), Enanta Pharmaceuticals (ENTA) and Arrowhead Pharmaceuticals (ARWR)Analysts have been eager to weigh in on the Healthcare sector with new ratings on Agilent (A – Research Report), Enanta Pharmaceuticals (ENTA – Research Report) and Arrowhead Pharmaceuticals (ARWR – Research Report). Agilent (A) Leerink Partners analyst Puneet Souda maintained a Buy rating on Agilent today and set a price target of $175.00. The company's shares closed last Monday at $162.78. According to TipRanks. |
Analysts’ Top Healthcare Picks: Seagen (SGEN), Agilent (A)There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Seagen (SGEN – Research Report), Agilent (A – Research Report) and Enanta Pharmaceuticals (ENTA – Research Report) with bullish sentiments. Seagen (SGEN) H.C. Wainwright analyst Andrew Fein maintained a Buy rating on Seagen today and set a price target of $200.00. The company's shares closed last Monday at $176.12. According to TipRanks. |
Agilent to Present at Evercore ISI Virtual Healthcare ConferenceSANTA CLARA, Calif., November 23, 2021--Agilent to present at Evercore ISI Virtual Healthcare Conference. |
Agilent's (A) Q4 Earnings & Revenues Beat Estimates, Rise Y/YAgilent Technologies' (A) fourth-quarter fiscal 2021 results reflect a solid end-market momentum and strong growth across Americas and China. |
10 Stocks in The Limelight After Quarterly ReportsIn this article, we will take a look at the 10 stocks in the limelight after quarterly reports. You can skip our detailed analysis of these companies, and go directly to the 5 Stocks in The Limelight After Quarterly Reports. U.S. stocks from consumer cyclical, healthcare, communication services, and technology sectors recently released their quarterly […] |
Agilent Technologies Inc (A) Q4 2021 Earnings Call TranscriptA earnings call for the period ending October 31, 2021. |